Well , hopefully we be approved for MOA for 22 solid tumors , without proving each..

Test like CD4 I believe we checking with all diseases ..

Do we need studies with other diseases imo, yes , I believe we need to prove by study that we working in humans , and this is not a bad thing..

Because our NASH pre-clinical studies are very good , don't mean it will work on humans ..

But FDA know safety of Leronlimab , so in further diseases we should be proving mostly efficacy for particular disease....and I am against placebo when we dealing with dying patients like here with severe sick CV patients..



But all imo..






IMO as always...